Plain-English translation of NCT04753840 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Hypertension research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a combination treatment for mild high blood pressure: a device called remote ischemic preconditioning (RIPC) that uses a blood pressure cuff on your arm, paired with guided mindfulness meditation. Researchers want to see if using this cuff device twice daily for 12 weeks, along with mindfulness practice, can help lower your blood pressure more effectively than other approaches. The study will measure your blood pressure changes and look at chemicals in your blood that affect blood vessel health.
Many people with mild high blood pressure don't respond well to medication alone, or prefer to try other approaches first. This trial is exploring whether combining a device-based treatment with mindfulness—a technique that has shown promise for stress and blood pressure—might offer a new, drug-free or drug-sparing option for managing hypertension.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic before the study starts and again after 12 weeks for blood pressure monitoring and blood tests. During the 12 weeks, you'll use a specialized cuff device at home twice daily—each session lasts about 30 minutes and involves cycles of the cuff inflating and deflating. You'll also listen to guided mindfulness audio sessions (also twice daily) that teach you to focus on your breathing and body sensations. The researchers will check your blood pressure trends and measure hormone levels in your blood to see how the treatment affects your cardiovascular system.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
China